Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 186 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A 52-week Study of Remibrutinib in IgE-mediated Food Allergy

 		IgE-Mediated Food Allergy, Peanut Allergy, Cow Milk Allergy, Egg Allergy Phase3 United States NCT07768371

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

 		Cutaneous Lichen Planus Phase2 Australia
United States 		NCT07775924

A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment

 		Primary Immune Thrombocytopenia United States NCT07786077

A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

 		Multiple Sclerosis United States NCT07779460

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

 		Asthma Phase3 Poland
South Africa 		NCT05776927

Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)

 		Chronic Spontaneous Urticaria Germany NCT07642557

A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag

 		Immune Thrombocytopenia Switzerland NCT07587723

HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension

 		Elevated Blood Pressure, Hypertension Phase1 Japan NCT07644364

A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

 		Plaque Psoriasis, Metabolic Dysfunction-Associated Steatotic Liver Disease Spain NCT07683065

A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

 		Cryptosporidiosis Kenya
Malaysia
Zambia 		NCT07716410